Pharmacokinetics of ticarcillin in the loggerhead sea turtle, Caretta caretta, after single intravenous and intramuscular injections.

Manire, Charles A.

dc.contributor.author	Manire, Charles A.
dc.date.accessioned	2013-04-26T15:20:16Z
dc.date.available	2013-04-26T15:20:16Z
dc.date.issued	2003
dc.identifier.uri	http://hdl.handle.net/2075/3177
dc.description	17 p. pdf. Includes bibliographical references, charts and tables.	en_US
dc.description.abstract	Pharmacokinetic studies of drugs used in endangered and threatened sea turtles are extremely limited. This study was undertaken to provide a drug dosage for sea turtles for ticarcillin, a semi-synthetic anti-pseudomonal beta-lactam antibiotic. Three captive loggerhead sea turtles were used in four trials, one intravenous and three intramuscular, to determine the pharmacokinetic properties of single dose ticarcillin in the species. Activities of the project and results are described.	en_US
dc.description.sponsorship	Florida Fish and Wildlife Conservation Commission, Marine Turtle Grants Program, FWC Contract No. 02003, Marine Turtle Grant #02-004.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Mote Marine Laboratory, Sarasota, FL	en_US
dc.relation.ispartofseries	Mote Technical Report;No. 930
dc.subject	sea turtles	en_US
dc.subject	marine turtles	en_US
dc.subject	loggerhead turtle	en_US
dc.subject	Caretta caretta	en_US
dc.title	Pharmacokinetics of ticarcillin in the loggerhead sea turtle, Caretta caretta, after single intravenous and intramuscular injections.	en_US
dc.type	Technical Report	en_US